Ledger.Open graph →
SEC Form D · filed March 7, 2024

CALOSYN PHARMA, INC

Offering
$2.0M
Sold
$750K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Shreveport, LA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Ross P. Barrett · Shreveport, LAExec · DirectorJoseph P. Lovett · Baton Rouge, LADirectorRoss P. Barrett · Shreveport, LAExec · DirectorRichard R. Babb · Baton Rouge, LAExec · DirectorDavid P. Waddell · Shreveport, LADirectorWilliam R. Grimes · Kaufman, TXExec · DirectorJames Garrett · New York, NYExec · DirectorJoseph P. Lovett · Baton Rouge, LADirectorRichard R. Babb · Baton Rouge, LAExec · DirectorDavid P. Waddell · Shreveport, LADirectorWilliam R. Grimes · Shreveport, LAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗